Announcements Trials

Browse Landscape

Phase

Status

Completed 7 Unknown 1 Recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2 Other 1 Genitourinary 1 Endocrine 1 Breast 1

Conditions

Breast Neoplasms 1780 Triple Negative Breast Neoplasms 299 Ovarian Neoplasms 136 Lung Neoplasms 115 Colorectal Neoplasms 115 Neoplasms 106 Prostatic Neoplasms 103 Carcinoma, Non-Small-Cell Lung 101 Neoplasm Metastasis 96 Stomach Neoplasms 81 Pancreatic Neoplasms 78 Melanoma 74 Endometrial Neoplasms 65 Head and Neck Neoplasms 60 Uterine Cervical Neoplasms 56 Squamous Cell Carcinoma of Head and Neck 50 Colonic Neoplasms 45 Esophageal Neoplasms 42 Sarcoma 41 Carcinoma, Intraductal, Noninfiltrating 41 Motor Activity 37 HER2-positive Breast Cancer 34 Urinary Bladder Neoplasms 33 Liver Neoplasms 31 Carcinoma, Renal Cell 30 Brain Neoplasms 28 Advanced Breast Cancer 25 Lymphedema 24 Kidney Neoplasms 24 Carcinoma, Transitional Cell 23

Interventions

Tamoxifen 1 Letrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Infertility × Breast × Clear all

NCT03011684 2026-06-04

TALES

University of California, San Francisco

Phase 3 Recruiting

Breast Neoplasms, Infertility

Data powered by HemOnc (CC BY 4.0) Colophon ⚡